Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D'Andrea

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Blood Advances|November 19, 2025
Fancl-mutant mice reveal central role of monoubiquitination in Fanconi anemia and a model for therapeutic gene editingLu Liu, Astrid Glaser, Abdulsalam I Isiaku, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemiaSubhash C Prajapati, Cem Meydan, Yaseswini Neelamraju, et al.
Cancer Research|December 17, 2013
Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profilingKathleen I Pishas, Susan J Neuhaus, Mark T Clayer, et al.
Blood|October 7, 2009
Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AMLJason A Powell, Daniel Thomas, Emma F Barry, et al.
Blood|April 5, 2024
Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AMLNunki Hassan, Hangyu Yi, Bilal Malik, et al.
Scientific Reports|May 28, 2017
A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasmD A Casolari, T Nguyen, C M Butcher, et al.
Neoplasia (New York, N.Y.)|March 17, 2026
CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemiaSubhash C Prajapati, Cem Meydan, Yaseswini Neelamraju, et al.
Blood|March 8, 2024
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activationLih En Hong, Mihir D Wechalekar, Monika Kutyna, et al.
Leukemia|April 14, 2021
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancerDeepak Singhal, Christopher N Hahn, Simone Feurstein, et al.
Nature Communications|May 13, 2022
Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemiaMahmoud A Bassal, Saumya E Samaraweera, Kelly Lim, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Blood Advances|November 19, 2025
Fancl-mutant mice reveal central role of monoubiquitination in Fanconi anemia and a model for therapeutic gene editingLu Liu, Astrid Glaser, Abdulsalam I Isiaku, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemiaSubhash C Prajapati, Cem Meydan, Yaseswini Neelamraju, et al.
Cancer Research|December 17, 2013
Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profilingKathleen I Pishas, Susan J Neuhaus, Mark T Clayer, et al.
Blood|October 7, 2009
Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AMLJason A Powell, Daniel Thomas, Emma F Barry, et al.
Blood|April 5, 2024
Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AMLNunki Hassan, Hangyu Yi, Bilal Malik, et al.
Scientific Reports|May 28, 2017
A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasmD A Casolari, T Nguyen, C M Butcher, et al.
Neoplasia (New York, N.Y.)|March 17, 2026
CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemiaSubhash C Prajapati, Cem Meydan, Yaseswini Neelamraju, et al.
Blood|March 8, 2024
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activationLih En Hong, Mihir D Wechalekar, Monika Kutyna, et al.
Leukemia|April 14, 2021
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancerDeepak Singhal, Christopher N Hahn, Simone Feurstein, et al.
Nature Communications|May 13, 2022
Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemiaMahmoud A Bassal, Saumya E Samaraweera, Kelly Lim, et al.
Pageof 9